The Path to Personalized Medicine.

Hamburg, M. A., & Collins, F. S. (2010). The Path to Personalized Medicine. New England Journal of Medicine, 363(4), 301-304.

Type

Journal article

Intellectual base

Primary research

Year

2010

DOI

10.1056/nejmp1006304

Link

https://doi.org/10.1056/NEJMp1006304

Cited from

economics_finance

Cited by

1 citation across 1 artifact.

Each citation links to the sentence it supports in the citing article.

Primes

• Distributional Effects
  • In drug development, average dose-response hides responder/non-responder distinctions, and personalized medicine is the explicit move to act on the distribution rather than the average.

    This sourceArgues personalized medicine acts on responder/non-responder heterogeneity rather than the average dose-response.

Verification

This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.

Registry ID ref:e637a20ab0af · see in the full table